Salomon & Ludwin’s Dentsply Sirona XRAY Stock Holding History

Salomon & Ludwin’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-137	Closed	-$1.81K	–	2225
2025 Q3	$1.81K	Buy	+137	New	+$1.99K	﹤0.01%	1992

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Salomon & Ludwin's XRAY Position: Q4 2025 in Review

Salomon & Ludwin sold out of Dentsply Sirona (XRAY) in Q4 2025, closing a stake of 137 shares — an estimated $1.81K sold.

Salomon & Ludwin first reported a position in XRAY in Q3 2025 and held it in 1 quarter. The position peaked at $1.81K in Q3 2025. 362 funds tracked by Wall St. Rank hold XRAY as of Q4 2025.

Salomon & Ludwin reported no remaining Dentsply Sirona position as of Q4 2025 after selling out during the quarter.
Salomon & Ludwin sold 137 Dentsply Sirona shares in Q4 2025, an estimated $1.81K.
Salomon & Ludwin first reported a position in Dentsply Sirona in Q3 2025 and held it in 1 quarter.
Salomon & Ludwin's Dentsply Sirona position peaked at $1.81K in Q3 2025.
362 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2025.

Based on Salomon & Ludwin's 13F filing for Q4 2025, filed 28 Jan 2026.